Grifols S.A. Cl B | Mutual Funds
Mutual Funds that own Grifols S.A. Cl B
American Funds EuroPacific Growth Fund
9,697,000
3.71%
0
0.14%
06/30/2018
American Funds Growth Fund of America
7,740,000
2.96%
0
0.09%
06/30/2018
American Funds Capital World Growth & Income Fund
6,770,000
2.59%
0
0.16%
06/30/2018
American Funds New World Fund
4,722,154
1.81%
0
0.3%
06/30/2018
American Funds New Perspective Fund
3,791,766
1.45%
0
0.1%
06/30/2018
American Funds Insurance Series - International Fund
3,304,730
1.26%
0
0.82%
06/30/2018
Fidelity Series International Value Fund
3,097,238
1.19%
0
0.46%
07/31/2018
Vanguard Total International Stock Index Fund
2,973,982
1.13%
0
0.02%
07/31/2018
Santander Acciones Españolas, FI
2,768,693
1.06%
426,958
4%
03/31/2018
Oddo Génération
1,736,186
0.66%
352,078
3.37%
04/30/2018
| Address |
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
|
|
Employees
|
- |
| Website |
http://www.grifols.com |
| Updated |
07/08/2019 |
| Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. |
